EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

NEAT1 repression by MED12 creates chemosensitivity in p53 wild‐type breast cancer cells

Shengjie Zhang, Eui-Jun Kim, Junfeng Huang, Peng Liu, Kristine Donahue, Qinchuan Wang, Yidan Wang, Sean Mcilwain, Ling Xie, Xian Chen, Lingjun Li, Wei Xu iD

The FEBS Journal · 2024

DOI: 10.1111/febs.17097 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, 2024. Verfasst von Shengjie Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, WI, USA. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Breast Neoplasms, Tumor Suppressor Protein p53, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is often treated with chemotherapy. However, the development of chemoresistance results in treatment failure. Long non‐coding RNA nuclear paraspeckle assembly transcript 1 ( NEAT1 ) has been shown to contribute to chemoresistance in breast cancer cells. In studying the transcriptional regulation of NEAT1 using multi‐omics approaches, we showed that NEAT1 is up‐regulated by 5‐fluorouracil in breast cancer cells with wild‐type cellular tumor antigen p53 but not in mutant‐p53‐expressing breast cancer cells. The regulation of NEAT1 involves mediator complex subunit 12 (MED12)‐mediated repression of histone acetylation marks at the promoter region of NEAT1 . Knockdown of MED12 but not coactivator‐associated arginine methyltransferase 1 ( CARM1 ) induced histone acetylation at the NEAT1 promoter, leading to elevated NEAT1 mRNAs, resulting in a chemoresistant phenotype. The MED12‐dependent regulation of NEAT1 differs between wild‐type and mutant p53‐expressing cells. MED12 depletion led to increased expression of NEAT1 in a wild‐type p53 cell line, but decreased expression in a mutant p53 cell line. Chemoresistance caused by MED12 depletion can be partially rescued by NEAT1 knockdown in p53 wild‐type cells. Collectively, our study reveals a novel mechanism of chemoresistance dependent on MED12 transcriptional regulation of NEAT1 in p53 wild‐type breast cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingBreast NeoplasmsTumor Suppressor Protein p53Drug Resistance, NeoplasmMediator ComplexGene Expression Regulation, NeoplasticHumansFemaleFluorouracilCell Line, TumorPromoter Regions, GeneticProtein-Arginine N-MethyltransferasesAcetylationHistones

Stichwörter der Autor:innen

NEAT1MED12breast cancerchemosensitivityhistone acetylation

Substanzen

RNA, Long NoncodingNEAT1 long non-coding RNA, humanTumor Suppressor Protein p53Mediator ComplexMED12 protein, humanTP53 protein, humanFluorouracilProtein-Arginine N-MethyltransferasesHistonescoactivator-associated arginine methyltransferase 1

Autor:innen und Institutionen

  • McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, WI, USA.
  • Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
  • School of Pharmacy, University of Wisconsin, Madison, WI, USA.
  • Department of Biostatistics and Medical Informatics, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.
  • Department of Biostatistics and Medical Informatics, Carbone Cancer Center, University of Wisconsin, Madison, WI, USA.
  • Department of Surgical Oncology, Affiliated Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.

ORCID-Profile: Wei Xu

Förderung

  • NCI NIH HHS
  • NIH HHS
  • NIA NIH HHS
  • NCRR NIH HHS
  • NIDDK NIH HHS
  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province
  • National Institutes of Health

Zitieren

APA

Zhang, S., Kim, E. J., Huang, J., Liu, P., Donahue, K., Wang, Q., Wang, Y., Mcilwain, S., Xie, L., Chen, X., Li, L., & Xu, W. (2024). NEAT1 repression by MED12 creates chemosensitivity in p53 wild‐type breast cancer cells. The FEBS Journal. https://doi.org/10.1111/febs.17097

Vancouver

Zhang S, Kim EJ, Huang J, Liu P, Donahue K, Wang Q, et al. NEAT1 repression by MED12 creates chemosensitivity in p53 wild‐type breast cancer cells. The FEBS Journal. 2024. doi:10.1111/febs.17097

BibTeX
@article{Zhang2024,
  author = {Zhang, Shengjie and Kim, Eui-Jun and Huang, Junfeng and Liu, Peng and Donahue, Kristine and Wang, Qinchuan and Wang, Yidan and Mcilwain, Sean and Xie, Ling and Chen, Xian and Li, Lingjun and Xu, Wei},
  title = {NEAT1 repression by MED12 creates chemosensitivity in p53 wild‐type breast cancer cells},
  journal = {The FEBS Journal},
  year = {2024},
  doi = {10.1111/febs.17097}
}
Kostenlos starten →